Europe
Again and again … and again, drugs have failed in clinical trials for Alzheimer’s disease. According to a new report, in the last decade, 146 drugs have failed in clinical trials for Alzheimer’s.
Roche and privately-held cell therapy company SQZ will jointly develop oncology products based on antigen presenting cells (APCs) that are created by the SQZ platform.
Heidelberg Pharma AG today announced that its partner Magenta Therapeutics (NASDAQ: MGTA), Cambridge, MA, USA, exercises its option to further develop a target molecule, and will now continue the development of an Antibody Targeted Amanitin Conjugate based on the target molecule within an exclusive licensing.
As many as 800 asthma deaths a year in the UK could be prevented by a new generation of ‘smart inhalers’, however, data concerns could be holding back roll out, says medical device developer and manufacturer, Bespak.
Joint optimization of groundbreaking resorbable medical device for treatment of full thickness wounds in oral cavities
Acquisition of Illumina NovaSeq instrument increases throughput & quality and reduces cost
Key milestones reached for GMP manufacturing of HDP-101
Who mixed things up in the biotech world this past week? Pfizer announces its leadership team, Rheos gets a new COO, and board of directors updates from multiple biopharma companies.
Depression affects almost 20 million Americans yearly and major depressive disorders affect nearly 300 million people worldwide. The annual market for these disorders is approximately $83 billion.
Secarna Pharmaceuticals announced today that the Company will receive an EU grant under the ERA-Net Co-fund scheme of the Horizon 2020 Research and Innovation Framework Programme for multidisciplinary and translational research and innovation projects (EuroNanoMed III). The duration of the grant is expected to be three years.
PRESS RELEASES